Top Stories

Grid List

Recipharm, the contract development and manufacturing organisation (CDMO), and LIDDS have together set up a manufacturing line for LIDDS’ novel prostate cancer drug, Liproca® Depot, at Recipharm in Solna, Sweden.

Epidemiologists conducting national precision medicine initiatives focused on gathering clinical research data on genetic variation among East and South Asian populations now have access to Thermo Fisher Scientific's Applied Biosystems Axiom Asia Precision Medicine Research Array.

AbbVie , a global biopharmaceutical company, and Principia Biopharma Inc., a private, clinical-stage biopharmaceutical company, announced today that they have entered a collaboration for the development of oral immunoproteasome inhibitors.

Spheryx, Inc. announced that the National Center for Advancing Translational Science (NCATS) of the NIH has awarded the company a Phase II SBIR grant for $1,500,000 over 2 years to support the modification of their proprietary Total Holographic Characterization® technology to meet the specific needs of the biologics pharmaceutical industry.

Viking Therapeutics, Inc , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced that enrollment has been completed in the company's ongoing Phase 2 clinical trial of VK5211 in patients who recently suffered a hip fracture.  

Cannabics Pharmaceuticals Inc announced it received positive results from screening necrosis (cell death) of circulating tumor cells, from cancer patients, treated with the cannabinoids CBD and CBDA.

Acasti Pharma Inc announced the achievement of a major corporate milestone by manufacturing the first cGMP batches of CaPre®, Acasti’s omega-3 pharmaceutical product candidate, produced with a proprietary and innovative continuous manufacturing process developed in partnership with CordenPharma.

Sartorius Stedim Biotech (SSB), a leading international supplier to the biopharmaceutical industry announced an agreement with Nova Biomedical (Nova), a well-known US manufacturer of cell culture analyzers, to integrate their BioProfile® FLEX2 into the ambr® multi-parallel bioreactor systems for automated, at-line cell culture analytics.

Contract development and manufacturing organisation (CDMO) Saneca Pharma has been granted a multiple dosage form approval for the manufacture and supply of solids, semi-solids and liquid finish dose products to Russia.

With the recent increase in health consciousness globally, the concept of "farm to fork" has swept the world. As a result of this, the search for methods to reduce food loss and waste in the supply chain from the farm to the dining table, has becomea critical problem to solve; from the perspectives of both economics and environmental protection.

A Spanish contract development and manufacturing organisation (CDMO) has expanded its GMP manufacturing offering with the installation of new automatic capsule filling capabilities at its EU-GMP approved plant in Pamplona, Spain.

Pharmapack Europe 2018 , Europe’s dedicated pharmaceutical packaging and drug delivery conference and exhibition, organised by UBM EMEA, is taking place on 7–8 February at Paris Expo Porte de Versailles, Paris.

Market Movers

Rogers Corporation

NYQ : ROG - 20 Jul, 4:02pm
118.27
+0.39 (+0.33%) After Hours:
Open 117.51 Mktcap 2.14B
High 118.33 52wk Hight 118.33
Low 116.08 52wk Low 51.98
Vol 86814 Avg Vol 128148
Eps 5.33 P/e 35.79
Currency: USD

Banco Santander, S.A. Sponsored

NYQ : SAN - 20 Jul, 4:03pm
6.67
+0.12 (+1.83%) After Hours:
Open 6.64 Mktcap 97.25B
High 6.69 52wk Hight 6.99
Low 6.62 52wk Low 3.89
Vol 73210 Avg Vol 7.87M
Eps 0.49 P/e 13.90
Currency: USD

Merck & Company, Inc. (new)

NYQ : MRK - 20 Jul, 4:00pm
62.94
+0.32 (+0.51%) After Hours:
Open 62.91 Mktcap 172.15B
High 63.24 52wk Hight 66.80
Low 62.85 52wk Low 57.18
Vol 6.66M Avg Vol 8.90M
Eps 3.85 P/e 40.11
Currency: USD

Johnson & Johnson

NYQ : JNJ - 20 Jul, 4:01pm
136.57
+1.36 (+1.01%) After Hours:
Open 135.73 Mktcap 367.90B
High 137.08 52wk Hight 137.08
Low 135.62 52wk Low 109.32
Vol 1388 Avg Vol 5.60M
Eps 7.17 P/e 22.96
Currency: USD

Pfizer, Inc.

NYQ : PFE - 20 Jul, 4:00pm
33.54
-0.08 (-0.24%) After Hours:
Open 33.47 Mktcap 200.16B
High 33.70 52wk Hight 37.39
Low 33.33 52wk Low 29.83
Vol 1053 Avg Vol 20.61M
Eps 2.55 P/e 28.23
Currency: USD

Direxion Daily 10-Yr Treasury B

PCX : TYO - 20 Jul, 3:59pm
13.90
-0.06 (-0.43%) After Hours:
Open 13.94 Mktcap
High 13.94 52wk Hight 16.29
Low 13.86 52wk Low 12.63
Vol 3822 Avg Vol 6067
Eps P/e
Currency: USD
Sign up via our free email subscription service to receive notifications when new information is available.
captcha 

Valeant Pharmaceuticals International, Inc announced that certain affiliates of the Company have entered into an agreement to sell its Obagi Medical Products business for $190 million in cash to Haitong International Zhonghua Finance Acquisition Fund I, L.P. Limited partners of the Fund include industry veterans in other geographic markets, such as China Regenerative Medicine International Limited .

Medicure Inc , a leading Canadian specialty pharmaceutical company, is pleased to announce that it has closed the acquisition of additional interests in Apicore Inc. and Apicore LLC (together "Apicore") from Apicore's founding shareholders as previously announced on July 10, 2017.

Valeant Pharmaceuticals International, Inc. announced that its affiliate has completed the sale of all of the outstanding equity interests in its former subsidiary Dendreon Pharmaceuticals LLC to the Sanpower Group, Co., Ltd. , for $819.9 million in cash.

Automation in its broadest sense has expanded from its original industrial manufacturing base to laboratories and businesses.

The deadlines for serialisation compliance in the EU and the U.S. are drawing closer. For many pharmaceutical companies, the journey towards implementing a full serialisation solution is well underway, but for others the complexity of the task means that there is still a lot to do. 

At the discovery and early stages of drug development, the aim is to evaluate the pharmacology, pharmacokinetics and toxicology of a compound using a simple liquid formulation.

BRITISH biotech business TopiVert has recently initiated clinical trials with two of its narrow spectrum kinase inhibitor (NSKI) drug candidates following support from Onyx Scientific.

At CPhI in Frankfurt, Omya will showcase its Omyapharm® multifunctional excipient platform based on functionalized calcium carbonate, a highly structured mineral.

Zenith Technologies has strengthened its global workforce, recruiting 100 people over the past year in response to growing demand for manufacturing execution system (MES) and automation technology in the pharma sector.